Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-cancer”

10,780 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 10,780 results

Not applicableStudy completedNCT07010224
What this trial is testing

Elastofibroma Dorsi: Clinical Features, Surgical Outcomes, and Risk Factors

Who this might be right for
Elastofibroma Dorsi
Ondokuz Mayıs University 102
Not applicableNot Yet RecruitingNCT07700823
What this trial is testing

Two-Point Versus Single-Point Serratus Anterior Plane Block for Post-Thoracoscopic Surgery Analgesia

Who this might be right for
Lung CancerPainVideo-Assisted Thoracoscopic Surgery+1 more
Shiyou Wei 88
Not applicableUnknownNCT04563780
What this trial is testing

The Prognostic Value of Post Thyroidectomy 99mTCpertechnetate Thyroid Scan in Patient With Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Cancer
Assiut University 113
Large-scale testing (Phase 3)Active Not RecruitingNCT04305496
What this trial is testing

Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer

Who this might be right for
Locally Advanced (Inoperable) or Metastatic Breast Cancer
AstraZeneca 818
Testing effectiveness (Phase 2)Active Not RecruitingNCT06004661
What this trial is testing

Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 23
Large-scale testing (Phase 3)Ended earlyNCT00312442
What this trial is testing

Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy

Who this might be right for
Prostate Cancer
STEBA France 16
Not applicableUnknownNCT04465942
What this trial is testing

Immunotherapy in Lung Cancer: Treatment After IO Cessation.

Who this might be right for
Carcinoma, Non-Small-Cell LungImmunotherapy
European Lung Cancer Working Party 300
Testing effectiveness (Phase 2)Ended earlyNCT01625741
What this trial is testing

Phase II Study of High-Dose Rituximab in High-Risk Chronic Lymphocytic Leukemia Patients in Suboptimal Response After Induction Immunochemotherapy

Who this might be right for
Chronic Lymphocytic Leukemia
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 6
Not applicableStudy completedNCT00775866
What this trial is testing

MRI-Guided Biopsy of Recurrent Prostate Cancer After Radiotherapy

Who this might be right for
Recurrent Prostate Cancer
University Health Network, Toronto 82
Not applicableEnded earlyNCT03570996
What this trial is testing

A Trial Comparing Transversus Abdominis Plane Catheter Versus Epidural After Esophagectomy

Who this might be right for
Esophageal CancerPain, Postoperative
Swedish Medical Center 38
Early research (Phase 1)Ended earlyNCT01801046
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Monoblastic Leukemia (M5a)Adult Acute Monocytic Leukemia (M5b)+24 more
University of Southern California 10
Not applicableStudy completedNCT01461070
What this trial is testing

Intestine Bacteria and Breast Cancer Risk

Who this might be right for
Breast Neoplasms
National Cancer Institute (NCI) 175
Not applicableActive Not RecruitingNCT06762470
What this trial is testing

Prognostic Value of CD4/CD8 Ratio in Patients with Nasopharyngeal Carcinoma

Who this might be right for
Histopathological Diagnosis of Nasopharyngeal CarcinomaPatients with Nasopharyngeal Carcinoma Without Distant Metastases After AJCC/UACC 8th Edition
Jiangxi Provincial Cancer Hospital 325
Testing effectiveness (Phase 2)Looking for participantsNCT06029270
What this trial is testing

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

Who this might be right for
Metastatic Nasopharyngeal CarcinomaRecurrent Nasopharyngeal CarcinomaStage IV Nasopharyngeal Carcinoma AJCC v8
National Cancer Institute (NCI) 156
Testing effectiveness (Phase 2)Study completedNCT00001566
What this trial is testing

A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas

Who this might be right for
Ewing's SarcomaRhabdomyosarcoma
National Cancer Institute (NCI) 42
Not applicableStudy completedNCT04175756
What this trial is testing

CAIman 5 Articulating Maryland in coloRECTAL Cancer Surgery

Who this might be right for
Colorectal Cancer
Aesculap AG 61
Testing effectiveness (Phase 2)Study completedNCT04633122
What this trial is testing

Assess DCC-2618 and Sunitinib in Patients With Advanced GIST After Treatment With Imatinib

Who this might be right for
Gastrointestinal Stromal Tumor(GIST)
Zai Lab (Shanghai) Co., Ltd. 108
Not applicableLooking for participantsNCT07110051
What this trial is testing

Nalbuphine Versus Tramadol on Post Operative Analgesia in Abdominal Surgery on Pediatric Cancer Patient

Who this might be right for
TramadolNalbuphineAbdominal Surgeries+1 more
National Cancer Institute, Egypt 128
Not applicableStudy completedNCT06960031
What this trial is testing

Added Value of PET/CT in Assessment of Hepatocellular Malignancy Post Radiofrequency Ablation

Who this might be right for
PET/CTHepatocellular MalignancyRadiofrequency Ablation
Tanta University 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT07192588
What this trial is testing

GR1014 Cutaneous Gel for the Prevention of Skin Reactions Caused by Radiation Therapy for Breast Cancer

Who this might be right for
Radiodermatitis; Acute
Graegis Pharmaceuticals Ltd 273
Next Page